1. Home
  2. HUMAW vs KTWOU Comparison

HUMAW vs KTWOU Comparison

Compare HUMAW & KTWOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

N/A

Current Price

$0.10

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

KTWOU

K2 Capital Acquisition Corporation Units

N/A

Current Price

$10.10

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HUMAW
KTWOU
Founded
2004
N/A
Country
United States
Cayman Islands
Employees
184
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
HUMAW
KTWOU
Price
$0.10
$10.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.1K
10.3K
Earning Date
03-21-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$10.03
52 Week High
$0.60
$11.13

Technical Indicators

Market Signals
Indicator
HUMAW
KTWOU
Relative Strength Index (RSI) 38.10 58.01
Support Level N/A $10.04
Resistance Level $0.10 $10.20
Average True Range (ATR) 0.01 0.19
MACD -0.00 0.00
Stochastic Oscillator 19.17 6.35

Price Performance

Historical Comparison
HUMAW
KTWOU

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About KTWOU K2 Capital Acquisition Corporation Units

K2 Capital Acquisition Corp is a blank check company.

Share on Social Networks: